Indicators of the quality of life in women with Graves’ disease after radioactive iodine treatment
Journal Title: Міжнародний ендокринологічний журнал - Year 2018, Vol 14, Issue 2
Abstract
Background. The purpose of the research was to evaluate the quality of life in women with Graves’ disease after radioactive iodine therapy. Materials and methods. We have examined 79 women with Graves’ disease after radioactive iodine treatment. The first group included 23 patients in euthyroid state, the second one — 56 women with hypothyroidism. The control group consisted of 15 women without thyroid pathology. Results. Women with Graves’ disease had a deterioration in the quality of life manifested by low indexes of both physical (by 30.3 %) and psychological (by 26.6 %) components of health. Conclusions. After radioactive iodine therapy, there was a significant improvement in the quality of life in women with Graves’ disease, and the total physical component increased by 38.2 %, psychological — by 33.4 %. Before treatment, the quality of life of women with Graves’ disease was significantly lower compared to the control group.
Authors and Affiliations
U. Z. Mirzaeva, Kh. R. Gulyamova
Laboratory and instrumental criteria for assessing the persistence of primary hyperparathyroidism within the first day after surgery. Retrospective assessment of risk
Background. The variability of laboratory results leads to an in-depth study of the past medical history and clinical picture, as well as diagnostic procedures to detect parathyroid glands with altered functional activit...
What was Known about Diabetes Mellitus in Ancient Times? (to Help Teachers and Students of Schools of Diabetes)
.
Combined Pathogenetic Therapy of Diabetic Distal Neuropathy
The data on the efficacy and safety of combined pathogenetic therapy in the treatment of distal neuropathy in diabetic patients are presented. There has been demonstrated a positive clinical effect in the combined use of...
New Opportunities in Prevention of Diabetes Mellitus Type 2
.
Outpatient Treatment of Patients with Diabetic Neuropathy with Alpha Lipoic Acid. Which Way of Administration We Need to Choose?
.